A correlative study using data from the cancer genome atlas found that DLBCLs with a low PD-L1 protein-to-mRNA ratio while also having higher relative expression levels of ADAM10 or ADAM17 had worse overall survival than high PD-L1 protein-to-mRNA counterparts (68). This evidence concerns the gene CD274 and cancer.